Corline Biomedical AB (OSTO:CLBIO) Total Liabilities : kr9.54 Mil (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Total Liabilities?

Corline Biomedical AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr9.54 Mil.

Corline Biomedical AB's quarterly Total Liabilities declined from Jun. 2023 (kr8.13 Mil) to Sep. 2023 (kr5.44 Mil) but then increased from Sep. 2023 (kr5.44 Mil) to Mar. 2024 (kr9.54 Mil).

Corline Biomedical AB's annual Total Liabilities increased from Dec. 2020 (kr6.24 Mil) to Dec. 2021 (kr9.43 Mil) but then declined from Dec. 2021 (kr9.43 Mil) to Dec. 2022 (kr7.19 Mil).

Corline Biomedical AB Total Liabilities Historical Data

The historical data trend for Corline Biomedical AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Total Liabilities Chart

Corline Biomedical AB Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Total Liabilities

Get a 7-Day Free Trial

7.95

4.43

6.24

9.43

7.19

Corline Biomedical AB Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Mar24
Total Liabilities	Get a 7-Day Free Trial															7.19	7.83	8.13	5.44	9.54

Corline Biomedical AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Corline Biomedical AB's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.194	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	7.19

Total Liabilities	=	Total Assets (A: Dec. 2022 )	-	Total Equity (A: Dec. 2022 )
	=	101.783	-	94.589
	=	7.19

Corline Biomedical AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.541	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	9.54

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	101.189	-	91.648
	=	9.54

Corline Biomedical AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Corline Biomedical AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Corline Biomedical AB (OSTO:CLBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lefflersgatan 5, Uppsala, SWE, 754 50

Website

http://www.corline.com

Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines